Navigation Links
U.S. Preventive Medicine Acquires Specialty Disease Management
Date:10/2/2007

DALLAS, Oct. 2 /PRNewswire/ -- U.S. Preventive Medicine(R) (http://www.USPreventiveMedicine.com) a company organizing and commercializing the market for proactive preventive health services, announced today the acquisition of Specialty Disease Management Services, Inc., a national provider of chronic condition and health management services based in Jacksonville, Fla. Terms of the deal were not disclosed.

The addition of Specialty Disease Management's leading-edge care management programs will enable U.S. Preventive Medicine to continue the expansion of its national network of integrated services and methodologies in the areas of preventive services, health benefits and chronic and complex disease management. To meet consumers and government demand for a larger focus on preventive medicine, U.S. Preventive Medicine is building a national brand of healthcare solutions by partnering with physicians, health systems, academic medical centers, government agencies and employers.

"We believe that current outcomes can be enhanced through the implementation of clinically proven preventive and care management solutions. Specialty Disease Management has developed a unique model for disease management that complements U.S. Preventive Medicine's prevention delivery capabilities," said Brian Baum, President and COO of U.S. Preventive Medicine. "We have a strong history and working relationship with Specialty Disease Management's team in achieving successful healthcare solutions. The combination of a proven team along with the delivery of personalized preventive health and comprehensive care management will allow us to offer the highest level of value."

Specialty Disease Management Services' business model, proven in government and commercial markets, incorporates highly trained clinical staff working with patients and their physicians over the phone and in the community. Their programs includ
'/>"/>

SOURCE U.S. Preventive Medicine
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
2. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
3. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
6. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
7. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
8. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
9. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
10. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
11. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2008)...ency of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, ...euticals,Corporation (TSX: NVN) today presented po...prietary Toll-like Receptor 3 agonist, Poly IC-Pol...ss 2008 in Lyon, France.,Study results demonstrate...ng the Toll-like Receptor 3 (TLR3) pathway. Data s...
(Date:10/8/2008)... clinical improvement in patients with pulmonary ...atment options have limited benefit for this debil...ood vessel disease, -- Imatinib mesylate, avail...ancers, known to inhibit protein associated with P... imatinib mesylate in PAH in 2009 EAST HANOV...
(Date:10/7/2008)...wswire/ -- McLaren Health Care and its Great,Lakes...s leading medical,minds to share the latest work u...tinal cancer treatments. The October 11th symposiu...Laren,s Sukamal Saha, M.D., an,award-winning surgi... for,colorectal cancer has gained worldwide recogn...
(Date:10/7/2008)...ewswire/ -- The Texas Cardiac Arrhythmia,Institute...ected as one of,only a few sites in the nation to ...a new device to treat persistent atrial fibrillati... research center specializing in heart,rhythm diso...l Center and,Texas Cardiovascular Consultants., "...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 1Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 3BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 1BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 2BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 3BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 4New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 1New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 2New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 3UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 1UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 2UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 3
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...Health Minister on the prescription issue. Under t...cribe in Wales. The move has been widely criticize...tion. "GPC Wales welcomes the statement of the H...rse and pharmacist prescribing in Wales. Doctors a...
...ochrane Collaboration (International private organ...rom various clinical trials) reviewed data from ov... and treatment. // The researchers found that th...uenza were not found to be effective now, some dru...
...ths due to medical errors are on the rise. Medical...n given on the drug labels. Food and Drug Administ...ght section //thereby making it easy for the docto...fore they could assess a drug as completely safe f...
...the twilight zone between life and death help the .... Dr Hasan Alam, a trauma surgeon at Massachusett...tails of this method. //In this method the surgeon...patients and perform the surgery. After the compl...
Other Medicine News:Health News:New Rule Results In The Complete Makeover In The Field Of Drug Advertising 2
Flattened Blunt Tip, Angled; 13mm from angle to tip; 3mm "U" shape tip; overall length excluding hub 28mm; in stainless steel.
Set of Five, Long, with side port; all approximately 75mm in length; in Stainless Steel.
HYDRACLEAR is our brandname for a remarkable moisture rich element that lies throughout the interior and exterior of the ACUVUE ADVANCE Brand Contact Lenses creating a unique soft, silky feel.
The only solution for in-line digital measurement
Medicine Products: